PRESS RELEASE published on 02/26/2025 at 07:30, 1 year 5 months ago BRAIN Biotech AG: 3M FY 24/25 - Starting the year with double digit sales growth in the core BRAINBiocatalysts division BRAIN Biotech AG reports 11% organic growth in Q1 of FY 24/25 for BRAINBiocatalysts, forecasts strong growth and solid EBITDA margin, maintains strong cash position of €17.8 million Financial Results EBITDA Margin Organic Growth BRAIN Biotech AG BRAINBiocatalysts
BRIEF published on 02/13/2025 at 09:19, 1 year 6 months ago BRAIN Biotech s'associe au groupe PX pour le recyclage biologique de l'or Collaboration Recyclage Biologique BioXtracteur V2 Exploitation Minière Urbaine PX Or Durable
BRIEF published on 02/13/2025 at 09:19, 1 year 6 months ago BRAIN Biotech Partners with PX Group for Biological Gold Recycling Collaboration Biological Recycling BioXtractor V2 PX Urban Mining Sustainable Gold
PRESS RELEASE published on 02/13/2025 at 09:14, 1 year 6 months ago Biological gold recycling: BRAIN Biotech AG collaborates with PX Group on the PX Urban Mining Initiative BRAIN Biotech AG collaborates with PX Group on the PX Urban Mining Initiative for biological gold recycling, producing BioGold nuggets from local waste. Focus on sustainability Sustainability BRAIN Biotech AG PX Group Urban Mining Initiative Gold Recycling
BRIEF published on 01/15/2025 at 07:35, 1 year 7 months ago BRAIN Biotech AG maintient une solide position de trésorerie malgré un exercice 2023/24 difficile Résultats Financiers Perspectives De Croissance Stabilité Des Revenus Situation De Trésorerie Transactions Stratégiques
BRIEF published on 01/15/2025 at 07:35, 1 year 7 months ago BRAIN Biotech AG Maintains Strong Cash Position Amidst Challenging FY 2023/24 Financial Results Cash Position Strategic Transactions Growth Prospects Revenue Stability
PRESS RELEASE published on 01/15/2025 at 07:30, 1 year 7 months ago Annual Report 2023/24: BRAIN Biotech AG acts from a strong cash position and is confident about its growth prospects BRAIN Biotech AG reports strong cash position & growth prospects in Annual Report 2023/24. Closed milestone transactions with Royalty Pharma & Akribion Therapeutics Cash Position Annual Report Growth Prospects BRAIN Biotech AG Milestone Transactions
BRIEF published on 12/12/2024 at 09:05, 1 year 8 months ago BRAIN Biotech AG Refocuses on Profitable Growth Profitable Growth Financial Forecast Strategic Initiatives BRAIN Biotech Enzyme Business
BRIEF published on 12/12/2024 at 09:05, 1 year 8 months ago BRAIN Biotech AG se recentre sur une croissance rentable Croissance Rentable Prévisions Financières CERVEAU Biotechnologie Initiatives Stratégiques Entreprise D'enzymes
PRESS RELEASE published on 12/12/2024 at 09:00, 1 year 8 months ago BRAIN Biotech AG Sharpens Focus on Profitable Growth BRAIN Biotech AG sharpens focus on profitable growth by creating new growth segment BRAINBiocatalysts. Targets include EUR 100 million revenues, 15% adjusted EBITDA margin, and high R&D ratio Profitable Growth Financial Forecast BRAIN Biotech AG Enzyme Business BRAINBiocatalysts
Published on 08/20/2026 at 15:30, 4 hours 38 minutes ago Caldwell Announces Promotion of Lindsay Schoen Lane to Partner
Published on 08/20/2026 at 15:15, 4 hours 53 minutes ago Reporting Results for the Six Months Ended June 30, 2026
Published on 08/20/2026 at 15:00, 5 hours 8 minutes ago Portfolio Update - Strategic Investment in Maravilla Oil and Gas
Published on 08/20/2026 at 15:00, 5 hours 8 minutes ago Vox Royalty Enters into Binding Agreement to Acquire Australian Copper and Gold Royalty Portfolio
Published on 08/20/2026 at 14:35, 5 hours 33 minutes ago Wi2Wi Reports 59% Revenue Growth to US$2.32M and Returns to Profitability with US$251K Net Income in Q2 2026
Published on 08/20/2026 at 18:42, 1 hour 25 minutes ago EQS-Adhoc: Fielmann Group AG updates guidance for the 2026 financial year amid continued consumer uncertainty in Germany
Published on 08/20/2026 at 18:35, 1 hour 33 minutes ago Fresenius raises approximately €300 million through sale of 7.8 million Fresenius Medical Care shares
Published on 08/20/2026 at 18:00, 2 hours 8 minutes ago FLORENTAISE: Le Tribunal de Commerce de Nantes approuve le plan de redressement proposé par Florentaise - Fin de la procédure de redressement judiciaire Mise en place d’une nouvelle gouvernance
Published on 08/20/2026 at 17:45, 2 hours 23 minutes ago CTS EVENTIM generates double-digit increases in revenue and earnings in the first half of 2026
Published on 08/18/2026 at 18:00, 2 days 2 hours ago KLARSEN : Nomonation Olivier Cornelis DG ITL et webinaire
Published on 08/18/2026 at 17:45, 2 days 2 hours ago Mise à disposition du rapport financier annuel 2025-26
Published on 08/18/2026 at 11:15, 2 days 8 hours ago GUILLEMOT CORPORATION | Déclaration hebdomadaire des transactions sur actions propres du 10 au 14 août 2026
Published on 08/18/2026 at 11:15, 2 days 8 hours ago GUILLEMOT CORPORATION | Weekly report share buyback from August 10 to August 14 2026
